Bornkamm, Delius, Zimber et Hudewentz, « Comparison of Epstein–Barr virus strains of different origin by analysis of the viral DNAs », Journal of Virology, vol. 35, no 3, , p. 603–618 (PMID6252328, PMCID288854, DOI10.1128/JVI.35.3.603-618.1980)
North, Morgan, Thompson et Epstein, « Purified Epstein-Barr virus Mr 340,000 glycoprotein induces potent virus-neutralizing antibodies when incorporated in liposomes », Proceedings of the National Academy of Sciences of the United States of America, vol. 79, no 23, , p. 7504–7508 (PMID6296836, PMCID347368, DOI10.1073/pnas.79.23.7504, Bibcode1982PNAS...79.7504N)
Gaston, Rickinson, Yao et Epstein, « The abnormal cytotoxic T cell response to Epstein–Barr virus in rheumatoid arthritis is correlated with disease activity and occurs in other arthropathies », Annals of the Rheumatic Diseases, vol. 45, no 11, , p. 932–936 (PMID2878645, PMCID1002022, DOI10.1136/ard.45.11.932)
Henri Gruffat et Evelyne Manet, « Sir Anthony Epstein (1921–2024) : le découvreur du virus d’Epstein-Barr », Médecine/Sciences, vol. 40, nos 8-9, , p. 665 (DOI10.1051/medsci/2024090, lire en ligne, consulté le )
Henri Gruffat et Evelyne Manet, « Sir Anthony Epstein (1921–2024) : le découvreur du virus d’Epstein-Barr », Médecine/Sciences, vol. 40, nos 8-9, , p. 665 (DOI10.1051/medsci/2024090, lire en ligne, consulté le )
harvard.edu
ui.adsabs.harvard.edu
North, Morgan, Thompson et Epstein, « Purified Epstein-Barr virus Mr 340,000 glycoprotein induces potent virus-neutralizing antibodies when incorporated in liposomes », Proceedings of the National Academy of Sciences of the United States of America, vol. 79, no 23, , p. 7504–7508 (PMID6296836, PMCID347368, DOI10.1073/pnas.79.23.7504, Bibcode1982PNAS...79.7504N)
Bornkamm, Delius, Zimber et Hudewentz, « Comparison of Epstein–Barr virus strains of different origin by analysis of the viral DNAs », Journal of Virology, vol. 35, no 3, , p. 603–618 (PMID6252328, PMCID288854, DOI10.1128/JVI.35.3.603-618.1980)
North, Morgan, Thompson et Epstein, « Purified Epstein-Barr virus Mr 340,000 glycoprotein induces potent virus-neutralizing antibodies when incorporated in liposomes », Proceedings of the National Academy of Sciences of the United States of America, vol. 79, no 23, , p. 7504–7508 (PMID6296836, PMCID347368, DOI10.1073/pnas.79.23.7504, Bibcode1982PNAS...79.7504N)
Gaston, Rickinson, Yao et Epstein, « The abnormal cytotoxic T cell response to Epstein–Barr virus in rheumatoid arthritis is correlated with disease activity and occurs in other arthropathies », Annals of the Rheumatic Diseases, vol. 45, no 11, , p. 932–936 (PMID2878645, PMCID1002022, DOI10.1136/ard.45.11.932)
Epstein et Morgan, « Clinical consequences of Epstein–Barr virus infection and possible control by an anti-viral vaccine », Clinical and Experimental Immunology, vol. 53, no 2, , p. 257–271 (PMID6309441, PMCID1535689)
Rickinson, Finerty et Epstein, « Interaction of Epstein–Barr virus with leukaemic B cells in vitro. I. Abortive infection and rare cell line establishment from chronic lymphocytic leukaemic cells », Clinical and Experimental Immunology, vol. 50, no 2, , p. 347–354 (PMID6295671, PMCID1536694)
Rickinson, Crawford et Epstein, « Inhibition of the in vitro outgrowth of Epstein–Barr virus-transformed lymphocytes by thymus-dependent lymphocytes from infectious mononucleosis patients », Clinical and Experimental Immunology, vol. 28, no 1, , p. 72–79 (PMID193663, PMCID1540876)
Yao, Rickinson, Gaston et Epstein, « Disturbance of the Epstein-Barr virus-host balance in rheumatoid arthritis patients: A quantitative study », Clinical and Experimental Immunology, vol. 64, no 2, , p. 302–310 (PMID3017620, PMCID1542331)
Epstein, Randle, Finerty et Kirkwood, « Not all potently neutralizing, vaccine-induced antibodies to Epstein-Barr virus ensure protection of susceptible experimental animals », Clinical and Experimental Immunology, vol. 63, no 3, , p. 485–490 (PMID3011324, PMCID1577551)